TrialClinical cancer research : an official journal of the American Association for Cancer Research2021

FDA Approval Summary: Gilteritinib for Relapsed or Refractory Acute Myeloid Leukemia with a

E Dianne Pulte et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.